{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:54:32Z","timestamp":1790848472829,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Katz Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1245\/s10434-017-6242-3","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T16:52:13Z","timestamp":1511196733000},"page":"465-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II"],"prefix":"10.1245","volume":"25","author":[{"given":"Lauren M.","family":"Postlewait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara R.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Seamens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Delman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"6242_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"6242_CR2","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199\u2013206.","journal-title":"J Clin Oncol"},{"key":"6242_CR3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.6004\/jnccn.2016.0101","volume":"14","author":"DG Coit","year":"2016","unstructured":"Coit DG, Thompson JA, Algazi A, et al. NCCN guidelines insights: Melanoma, Version 3.2016. J Natl Compr Canc Netw. 2016;14:945\u201358.","journal-title":"J Natl Compr Cancer Netw"},{"key":"6242_CR4","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307\u201317.","journal-title":"N Engl J Med"},{"key":"6242_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599\u2013609.","journal-title":"N Engl J Med"},{"key":"6242_CR6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/SLA.0b013e318161312a","volume":"247","author":"MM Guggenheim","year":"2008","unstructured":"Guggenheim MM, Hug U, Jung FJ, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg. 2008;247:687\u201393.","journal-title":"Ann Surg."},{"key":"6242_CR7","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211\u201322.","journal-title":"N Engl J Med"},{"key":"6242_CR8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1445-2197.2003.t01-1-02622.x","volume":"73","author":"JW Serpell","year":"2003","unstructured":"Serpell JW, Carne PW, Bailey M. Radical lymph node dissection for melanoma. ANZ J Surg. 2003;73:294\u201399.","journal-title":"ANZ J Surg."},{"key":"6242_CR9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jamcollsurg.2013.12.016","volume":"218","author":"BM Martin","year":"2014","unstructured":"Martin BM, Etra JW, Russell MC, et al. Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma. J Am Coll Surg. 2014;218:620\u201326.","journal-title":"J Am Coll Surg"},{"key":"6242_CR10","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1245\/s10434-010-1026-z","volume":"17","author":"SB Chang","year":"2010","unstructured":"Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17:2764\u201372.","journal-title":"Ann Surg Oncol"},{"key":"6242_CR11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13193-011-0078-2","volume":"2","author":"P Brar","year":"2011","unstructured":"Brar P, Jain S, Singh I. Complications of axillary lymph node dissection in treatment of early breast cancer: a comparison of MRM and BCS. Indian J Surg Oncol. 2011;2:126\u201332.","journal-title":"Indian J Surg Oncol"},{"key":"6242_CR12","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25:3657\u201363.","journal-title":"J Clin Oncol"},{"key":"6242_CR13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1445-1433.2004.02992.x","volume":"74","author":"KO Taylor","year":"2004","unstructured":"Taylor KO. Morbidity associated with axillary surgery for breast cancer. ANZ J Surg. 2004;74:314\u201317.","journal-title":"ANZ J Surg"},{"key":"6242_CR14","unstructured":"A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node (MSLT-II). https:\/\/clinicaltrials.gov ."},{"key":"6242_CR15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17:757\u201367.","journal-title":"Lancet Oncol"},{"key":"6242_CR16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1245\/ASO.2006.03.058","volume":"13","author":"SL Wong","year":"2006","unstructured":"Wong SL, Morton DL, Thompson JF, et al. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol. 2006;13:809\u201316.","journal-title":"Ann Surg Oncol"},{"key":"6242_CR17","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1245\/s10434-014-3758-7","volume":"21","author":"ZM Bamboat","year":"2014","unstructured":"Bamboat ZM, Konstantinidis IT, Kuk D, et al. Observation after a positive sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol. 2014;21:3117\u201323.","journal-title":"Ann Surg Oncol"},{"key":"6242_CR18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297\u2013305.","journal-title":"Lancet Oncol"},{"key":"6242_CR19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569\u201375.","journal-title":"JAMA"},{"key":"6242_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426\u2013432; discussion 432\u201323.","journal-title":"Ann Surg"},{"key":"6242_CR21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K","volume":"88","author":"P Schrenk","year":"2000","unstructured":"Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608\u201314.","journal-title":"Cancer"},{"key":"6242_CR22","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/(SICI)1097-0142(19981001)83:7<1362::AID-CNCR13>3.0.CO;2-2","volume":"83","author":"MA Warmuth","year":"1998","unstructured":"Warmuth MA, Bowen G, Prosnitz LR, et al. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer. 1998;83:1362\u201368.","journal-title":"Cancer"},{"key":"6242_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","volume":"28","author":"SL Kilbreath","year":"2016","unstructured":"Kilbreath SL, Refshauge KM, Beith JM, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29\u201336.","journal-title":"Breast."},{"key":"6242_CR24","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0959-8049(01)00067-3","volume":"37","author":"JM Ververs","year":"2001","unstructured":"Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001;37:991\u201399.","journal-title":"Eur J Cancer"},{"key":"6242_CR25","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ejso.2014.01.019","volume":"40","author":"MM Stuiver","year":"2014","unstructured":"Stuiver MM, Westerduin E, ter Meulen S, et al. Surgical wound complications after groin dissection in melanoma patients \u2014a historical cohort study and risk factor analysis. Eur J Surg Oncol. 2014;40:1284\u201390.","journal-title":"Eur J Surg Oncol"},{"key":"6242_CR26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ejso.2006.05.003","volume":"32","author":"M Vries de","year":"2006","unstructured":"de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol. 2006;32:785\u201389.","journal-title":"Eur J Surg Oncol"},{"key":"6242_CR27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejso.2008.10.012","volume":"35","author":"HP Poos","year":"2009","unstructured":"Poos HP, Kruijff S, Bastiaannet E, et al. Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol. 2009;35:877\u201383.","journal-title":"Eur J Surg Oncol."},{"key":"6242_CR28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.eururo.2009.07.003","volume":"56","author":"V Master","year":"2009","unstructured":"Master V, Ogan K, Kooby D, et al. Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique. Eur Urol. 2009;56:821\u201328.","journal-title":"Eur Urol"},{"key":"6242_CR29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1245\/s10434-009-0816-7","volume":"17","author":"KA Delman","year":"2010","unstructured":"Delman KA, Kooby DA, Ogan K, et al. Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma. Ann Surg Oncol. 2010;17:731\u201337","journal-title":"Ann Surg Oncol"},{"key":"6242_CR30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1245\/s10434-010-1490-5","volume":"18","author":"KA Delman","year":"2011","unstructured":"Delman KA, Kooby DA, Rizzo M, et al. Initial experience with videoscopic inguinal lymphadenectomy. Ann Surg Oncol. 2011;18:977\u201382.","journal-title":"Ann Surg Oncol"},{"key":"6242_CR31","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1245\/s10434-008-9885-2","volume":"15","author":"KY Bilimoria","year":"2008","unstructured":"Bilimoria KY, Balch CM, Bentrem DJ, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol. 2008;15:1566\u201376.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-6242-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-6242-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-6242-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T18:33:56Z","timestamp":1659897236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-6242-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["6242"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-6242-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}